2 dividend growth stocks I’d consider buying in May

These two shares could offer a potent mix of dividend growth and low valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

With inflation continuing to rise and forecast to move higher, stocks offering high levels of dividend growth could become more attractive to investors. In other words, a high yield may be insufficient if inflation remains stubbornly high over the medium term. Therefore, buying companies with low payout ratios and earnings growth potential could be a sound strategy. Here are two prime examples which could be worth buying today.

Mixed performance

Reporting on Thursday was specialist risk insurer Beazley (LSE: BEZ). Its trading statement for the first quarter of 2017 showed it has made a good start to the year, although its gross written premiums fell by 2%. Its premium rates on renewal business decreased by 1%, which is generally in line with the company’s expectations.

Looking ahead, Beazley has clear growth potential. Its recent acquisition of Creechurch Underwriters expands its speciality lines presence in Canada. This forms part of what appears to be a sound strategy to develop its non-US speciality lines business. Alongside this, the company will continue to focus on growth in the US, while also reorganising its life, accident and health business as well as political risks and contingency divisions. They will come together and could deliver synergies and improving profitability in the long run.

With Beazley trading on a price-to-earnings (P/E) ratio of 14.8, it seems to offer value for money at the present time. It yields 3%, which is 80 basis points lower than the FTSE 100’s dividend yield. However, with the company’s dividends being covered 2.3 times by profit, there appears to be scope for growth over the long term. Together with an upbeat outlook for the business given the changes it is making, now could be the right time to buy it.

Growth at a reasonable price

Also offering scope for higher dividends in future years is diversified property and casualty reinsurance specialist Novae Group (LSE: NVA). It currently pays out just 40% of its profit as a dividend. This figure could increase in future years and still provide the business with sufficient capital through which to invest for growth. As such, it would be unsurprising for dividend growth to at least match profit growth over the medium term.

Novae Group is forecast to record a rise in its bottom line of 17% in the current year, followed by further growth of 33% next year. This suggests a double-digit rise in shareholder payouts is on the cards. This could help to make the company’s dividend appeal much higher – especially since it currently has a rather lowly yield of 2.6%.

With Novae Group trading on a P/E ratio of 17.8, it seems to offer upside potential. When its rating is combined with the aforementioned growth rates, it equates to a price-to-earnings growth (PEG) ratio of just 0.7. This suggests that as well as strong income potential, it also offers scope for a significantly higher valuation.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »